Persones / Equip Humà

Maria Rubio Valera

Buscador de publicacions

Publicacions

  • Paut Kusturica M, Sanchez A, Lumbreras B, Huerta-Ramos ME, Aznar I and Rubio-Valera M.

    Assessing direct medical costs of children following a new prescription of ADHD medication.

    BMC HEALTH SERVICES RESEARCH . 25(1): 990-990.

    [doi:10.1186/s12913-025-13106-9]

  • Osorio D, Plana MN, Rubio-Valera M, Muñoz-Miguel J, Bolíbar I, Franco MT, Secanell-Espluga M, Soler M, Fernández-Torres P, Suclupe S, Salas-Gama K, Torres-López D and Ferreira-González I.

    Patient-Reported Incident Measure (PRIM) tools for reporting patient safety incidents: protocol for a scoping review.

    BMJ Open . 15(6): .

    [doi:10.1136/bmjopen-2024-096983]

  • Rubio-Valera M, Carbonell-Duacastella C, Peñarrubia-María MT, Pacheco E, Gabriela-Ricciardeli P, Aznar I and Gil MM.

    Insights on pediatric medication initiation: perceptions of caregivers and children.

    FRONTIERS IN PHARMACOLOGY . 16: 1612169-1612169. Nº de cites: 1

    [doi:10.3389/fphar.2025.1612169]

  • Andersohn F, Christensen MC, Creuwels L, Aznar I, Rubio-Valera M, Penning-van Beest F, Houben E, Hernandez P, Hakkarainen KM and Reines EH.

    Vortioxetine in the routine management of major depressive disorder: an analysis of European automated healthcare databases.

    CURRENT MEDICAL RESEARCH AND OPINION . 41(5): 867-877.

    [doi:10.1080/03007995.2025.2505692]

  • Fuente M, Cahir C, Passos VL, Bennett K, Walsh C, Hermida-González P, Peláez de Loño J, Abella MER, Baladon L, Rubio-Valera M, Serrano-Blanco A and Aznar I.

    Identifying longitudinal medication adherence patterns of antipsychotic treatments: A real-world cohort study in Catalonia, Spain

    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . : . Nº de cites: 1

    [doi:10.1111/bcp.16399]

  • Vargas I, Mogollón-Pérez AS, Eguiguren P, Torres AL, Peralta A, Rubio-Valera M, Jervelund SS, Borras JM, Dias S and Vázquez ML.

    Understanding the health system drivers of delayed cancer diagnosis in public healthcare networks of Chile, Colombia and Ecuador: A qualitative study with health professionals, managers and policymakers.

    SOCIAL SCIENCE & MEDICINE . 365: 117499-117499. Nº de cites: 1

    [doi:10.1016/j.socscimed.2024.117499]

  • Sebastián D, Beltrà M, Irazoki A, Sala D, Aparicio-García P, Aris C, Alibakhshi E, Rubio-Valera M, Palacín M, Castellanos J, Lores L and Zorzano A.

    TP53INP2-dependent activation of muscle autophagy ameliorates sarcopenia and promotes healthy aging

    Autophagy . 20(8): 1815-1824. Nº de cites: 7

    [doi:10.1080/15548627.2024.2333717]

  • Chavarría V, Rubio-Valera M, Domènech J, Baladon L, Mateu I, Arias de la Torre J, Alvarós J, Peña C, Dima AL and Serrano-Blanco A.

    Patient Satisfaction and Willingness to Continue with Telemental Health Care During and After the Early Period of SARS-CoV-2 Pandemic: A User Survey

    TELEMEDICINE AND E-HEALTH . 30(7): 1935-1943.

    [doi:10.1089/tmj.2023.0562]

  • Fuente M, Dima AL, Rubio-Valera M, Baladon L, Chavarría V, Fabrizio S, Peña C, Serra-Sutton V, Hermida-González P, de Loño JP, Rey-Abella ME, Aznar I and Serrano-Blanco A.

    Evaluation of adherence to antipsychotics: A real-world data study using four different dosing assumptions

    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . 90(6): 1480-1492. Nº de cites: 2

    [doi:10.1111/bcp.16042]

  • Parody-Rua E, Bustamante A, Montaner J, Rubio-Valera M, Serrano D, Pérez-Sánchez S, Sanchez A, Guevara-Cuellar C and Serrano-Blanco A.

    Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients.

    EUROPEAN JOURNAL OF HEALTH ECONOMICS . 24(4): 621-632. Nº de cites: 2

    [doi:10.1007/s10198-022-01495-1]